The CFRI CF Community Voices Podcast

A Review of Lenabasum Phase II Clinical Trial Results - James Chmiel, MD, MPH (Audio)

The role of anti-inflammatories in CF care is vital. Lenabasum, Corbus Pharmaceuticals' investigational drug that mimics the effects of endocannabinoids in regulating inflammation, has been tracked through the clinical trial process with tremendous optimism. Dr. Chmiel, Principal Investigator of CF-002 (lenabasum), and Division Chief for Pediatric Pulmonology, Allergy and Sleep Medicine at Indiana University School of Medicine, reviews the results of the recent Phase IIb trial, and its implications for the CF community.

Sponsored by Vertex Pharmaceuticals, Gilead Sciences, Chiesi USA, Genentech, and Viatris, with additional support from Corbus Pharmaceuticals.

A Review of Lenabasum Phase II Clinical Trial Results - James Chmiel, MD, MPH

The role of anti-inflammatories in CF care is vital. Lenabasum, Corbus Pharmaceuticals' investigational drug that mimics the effects of endocannabinoids in regulating inflammation, has been tracked through the clinical trial process with tremendous optimism. Dr. Chmiel, Principal Investigator of CF-002 (lenabasum), and Division Chief for Pediatric Pulmonology, Allergy and Sleep Medicine at Indiana University School of Medicine, reviews the results of the recent Phase IIb trial, and its implications for the CF community.

Sponsored by Vertex Pharmaceuticals, Gilead Sciences, Chiesi USA, Genentech, and Viatris, with additional support from Corbus Pharmaceuticals.

Greet Me Germ Free - The Update

In honor of National Handshake Day, CFRI’s CF Adult Advisory Committee is launching part two of their “Greet Me Germ Free” campaign to raise awareness of the hazards of hand shaking. Hand shaking is known to be a primary source for the transmission of disease, especially important in the times of COVID-19. In this podcast, members of the Committee talk about issues they’ve encountered with our hand-shaking culture, some ways they have found to work around it, and some fun alternatives to say hello.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, Chiesi USA, and Mylan Pharmaceuticals for their support of these podcasts.

 

Track: Freedom

Music by Oak Studios

https://youtu.be/2M2Gk68sfYw

 

–––––––––––––––––––––––––––––– My Itinerary by Tokyo Music Walker https://soundcloud.com/user-356546060 Creative Commons — Attribution 3.0 Unported — CC BY 3.0 Free Download / Stream: https://bit.ly/t-w-my-itinerary Music promoted by Audio Library https://youtu.be/AKy14wPxaSo –––––––––––––––––––––––––––––– 🎵 Track Info: Title: My Itinerary by Tokyo Music Walker Genre and Mood: Dance & Electronic + Romantic ——— 🎧 Available on: Spotify: https://spoti.fi/2YNS9dc iTunes: https://apple.co/2Yai1RJ Deezer: https://deezer.com/us/track/961112922 YouTube: https://youtube.com/watch?v=jNfw2c3pWrw SoundCloud: https://soundcloud.com/user-356546060... ——— 😊 Contact the Artist: Tokyo Music Walker: https://soundcloud.com/user-356546060 https://youtube.com/channel/UC3lLfvhp... https://open.spotify.com/artist/7cktl... https://music.apple.com/us/artist/tok... https://play.google.com/store/music/a... https://instagram.com/tokyo_music_wal... ———

COVID-19 and Cystic Fibrosis: Q&A Session #11 with Rick Moss, MD - June 24, 2020

Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. This session was recorded on June 24, 2020.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.

Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ

COVID-19 and Cystic Fibrosis: Q & A #10 with Rick Moss, MD - May 27, 2020

Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. This final session was recorded on May 27, 2020.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.

Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ

COVID-19 and Cystic Fibrosis: Q & A #9 with Rick Moss, MD - May 20, 2020

Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Please feel free to submit additional questions by email to sreveles@cfri.org. This session was recorded on May 20, 2020.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.

Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ

COVID-19 and Cystic Fibrosis: Q&A #8 with Rick Moss, MD - May 13, 2020

Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Please feel free to submit additional questions by email to sreveles@cfri.org. This most recent session was recorded on May 13, 2020.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.

Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ

COVID-19 & Cystic Fibrosis: Q&A Session #7 with Rick Moss, MD - May 6, 2020

Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Dr. Moss has generously offered to continue these Q&A sessions to keep us informed. Please feel free to submit additional questions by email to cfri@cfri.org. This most recent session was recorded on May 6, 2020.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.

COVID-19 and Cystic Fibrosis: Q&A Session #6 with Rick Moss, MD - April 29, 2020

Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Dr. Moss has generously offered to continue these Q&A sessions to keep us informed. Please feel free to submit additional questions by email to cfri@cfri.org. This most recent session was recorded on April 29, 2020.

We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.

Sticks and Stones: Healthy Bones in CF with Vinayak Jha, MD, MSc

Dr. Vinayak Jha, Physician of Pulmonary and Critical Care Medicine at the Adult CF center at California Pacific Medical Center in San Francisco, discusses the impact of cystic fibrosis upon bone health. Those with CF have high rates of osteopenia and osteoporosis, often occurring at a very young age. In this podcast, Dr. Jha discusses the reasons behind this and available interventions to maintain bone health.

CF Community Voices is generously sponsored by Vertex Pharmaceuticals, Genentech, Chiesi USA, and Gilead Sciences.